# Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer

> **NCT03507088** · NA · COMPLETED · sponsor: **Zhimin Shao** · enrollment: 36 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Fluoroestradiol (18F)

## Key facts

- **NCT ID:** NCT03507088
- **Lead sponsor:** Zhimin Shao
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-01
- **Primary completion:** 2018-07-01
- **Final completion:** 2018-07-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03507088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03507088, "Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03507088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*